• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Nameseparator for therapeutic purposes, membrane automated blood cell/plasma
Generic Nameseparator for therapeutic purposes, membrane automated blood cell/plasma
Asahi Kasei Medical Co., Ltd.
1-105 kanda jinbocho
tokyo 101-8-8101
PMA NumberP820033
Supplement NumberS005
Date Received08/18/2009
Decision Date03/16/2010
Product Code
MDP[ Registered Establishments with MDP ]
Advisory Committee Gastroenterology/Urology
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the plasmaflo op-05w(a). The device, is intended as a replacement for the plasmaflo ap-05h and the plasmaflo ap-05h(l). The device will be marketed under the trade name plasmaflo op-05w(a) and is indicated for use in therapeutic procedures requiring separation of plasma from whole blood.